These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1101486)

  • 1. Attempts to compare the effectiveness of blocking factors and enhancing antibodies in vivo and in vitro.
    Hasek M; Chutná J; Sládecek M; Machácková M; Bubeńik J; Matousek V
    Transplantation; 1975 Aug; 20(2):95-100. PubMed ID: 1101486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune status of mice tolerant of living cells. II. Continuous presence and nature of facilitation-enhancing antibodies in tolerant animals.
    Voisin GA; Kinsky RG; Duc HT
    J Exp Med; 1972 May; 135(5):1185-203. PubMed ID: 4623319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-mediated reactivity and serum blocking activity in tolerant rats. Studies on ten rats operationally tolerant to skin allografts using several independent assays.
    Wright PW; Bernstein ID; Hamilton B; Gluckman JC; HELLSTROM KE
    Transplantation; 1974 Jul; 18(1):46-55. PubMed ID: 4152086
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunological enhancement of muscle allografts induced by serum from tolerant rats.
    Gutmann E; Hasek M; Chutná J
    Folia Biol (Praha); 1978; 24(1):25-31. PubMed ID: 344077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IMMUNOLOGICAL HOMOGRAFT ENHANCEMENT. INTERACTIONS OF ANTISERUM AND SKIN AND TUMOR HOMOGRAFTS.
    BERNE BH
    Proc Soc Exp Biol Med; 1965 Jan; 118():228-33. PubMed ID: 14254554
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunological tolerance and tumor allografts in the brain.
    Hasek M; Chutna J; Sládecek M; Lodin Z
    Nature; 1977 Jul; 268(5615):68-9. PubMed ID: 887149
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of rat tumor allografts on the blood level of passively transferred alloantibodies.
    Buchsbaum DJ
    Proc Soc Exp Biol Med; 1972 Apr; 139(4):1197-201. PubMed ID: 4112429
    [No Abstract]   [Full Text] [Related]  

  • 8. Mixed leukocyte culture reactivity in operationally tolerant rats: Relationship of lymphocyte-mediated reactivity and serum-blocking activity.
    Bernstein ID; Hamilton BL; Wright PW; Burstein R; Hellstrom KE
    J Immunol; 1975 Jan; 114(1 Pt 2):320-5. PubMed ID: 123257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passive immunological enhancement of skin allografts in rats.
    Cohen I; Brautbar H; Nelken D
    Transplantation; 1971 Feb; 11(2):135-7. PubMed ID: 4931238
    [No Abstract]   [Full Text] [Related]  

  • 10. Serological responses of mice during active enhancement of tumour allografts.
    Mildenhall P; Nelson DS
    Br J Exp Pathol; 1968 Apr; 49(2):170-8. PubMed ID: 5646469
    [No Abstract]   [Full Text] [Related]  

  • 11. Spontaneous long-term acceptance of RT-1-incompatible liver allografts in inbred rats. Analysis of the immune status.
    Houssin D; Charpentier B; Gugenheim J; Baudot P; Tamisier D; Lang P; Gigou M; Bismuth H
    Transplantation; 1983 Dec; 36(6):615-20. PubMed ID: 6229069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated immunity and blocking serum activity to tolerated allografts in rats.
    Bansal SC; Hellström KE; Hellström I; Sjögren HO
    J Exp Med; 1973 Mar; 137(3):590-602. PubMed ID: 4570016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the sensitivity of in vivo detection of immunological tolerance in the xenogeneic system.
    Chutná J; Hasek M; Lodin Z; Holán V
    Immunol Lett; 1982 May; 4(5):275-7. PubMed ID: 7047387
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumor-specific active enhancement of a murine sarcoma.
    Bloom ET; Hildemann WH
    Tissue Antigens; 1971; 1(1):5-13. PubMed ID: 5154368
    [No Abstract]   [Full Text] [Related]  

  • 15. [SURVIVAL OF SKIN HOMOGRAFTS AFTER TREATMENT WITH SPECIFIC IMMUNE SERUMS (EXPERIMENTAL RESEARCH ON THE RAT)].
    SEGATO G; TENDELLA E; MANTOVANI-ORSETTI G; ROSA G
    Acta Chir Ital; 1964; 20():649-55. PubMed ID: 14256666
    [No Abstract]   [Full Text] [Related]  

  • 16. MATURATION OF ALLOIMMUNE RESPONSIVENESS IN MICE.
    BORAKER DK; HILDEMANN WH
    Transplantation; 1965 Mar; 3():202-23. PubMed ID: 14265495
    [No Abstract]   [Full Text] [Related]  

  • 17. Cell-mediated immunity and blocking serum activity before and after breakage of allograft tolerance in rats.
    Bansal SC; Hellström I; Hellström KE; Wright PW
    Transplantation; 1973 Dec; 16(6):610-20. PubMed ID: 4585385
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanisms of tumor-specific enhancement versus resistance toward a methylcholanthrene-induced murine sarcoma.
    Bloom ET; Hildemann WH
    Transplantation; 1970 Oct; 10(4):321-33. PubMed ID: 4927387
    [No Abstract]   [Full Text] [Related]  

  • 19. Survival of tumor allografts in rats treated with antithymocyte serum.
    Abandowitz HM; Basrur PK
    Z Naturforsch C; 1973; 28(9):631-2. PubMed ID: 4272308
    [No Abstract]   [Full Text] [Related]  

  • 20. Complete in vivo destruction of allografted sarcoma I cells by circulating antibodies.
    Kinsky R; Chouroulinkov I; Voisin GA
    Transplantation; 1970 Nov; 10(5):450-1. PubMed ID: 5490529
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.